Clinical Trials on 晚期 HR 阳性和 HER2 阴性乳腺癌； CDK4/6抑制剂治疗失败 in Czechia
总计2个结果
-
AstraZeneca主动，不招人ER 阳性 HER2 阴性乳腺癌奥地利, 比利时, 法国, 德国, 意大利, 英国, 美国, 加拿大, 印度, 台湾, 俄罗斯联邦, 大韩民国, 匈牙利, 日本, 墨西哥, 火鸡, 中国, 马来西亚, 西班牙, 捷克语, 葡萄牙, 波兰, 挪威, 保加利亚, 斯洛伐克, 智利, 瑞士
此页面是自动翻译的，不保证翻译的准确性。请参阅 英文版 对于源文本。
赞助者和合作者
- Letícia Ferreira da Mota
- GALIA AVRAHAMI
- Kenyatta University
- Bellus Health Inc
- The Department of Family and Community Medicine, Penn State College of Medicine
- Colorado Neurology
- Integrated Scientific Services (ISS) AG
- Tolera Therapeutics, Inc
- Professor Eric Y.H. Chen
- Clínica León XIII
- Institute of Malaria, Parasitology and Entomology, Ho Chi Minh City, Viet Nam
- Frank Lobbezoo
- Fundacion Epheta
- Ansh Labs
- Ammar Ribhi Abu shama
- SOM Innovation Biotech SA
- Chengchu Zhu
- University of Missouri, Kansas City
- Ji Huang
- SillaJen, Inc.
- 查看完整清单
CROs by country
- Contract Research Organizations in Albania
- Contract Research Organizations in Belgium
- Contract Research Organizations in Denmark
- Contract Research Organizations in Egypt
- Contract Research Organizations in Guatemala
- Contract Research Organizations in Guinea
- Contract Research Organizations in Kuwait
- Contract Research Organizations in Mauritania
- Contract Research Organizations in Myanmar
- Contract Research Organizations in Oman
- Contract Research Organizations in Portugal
- Contract Research Organizations in Sweden
- Contract Research Organizations in Switzerland
- CRO list by country